These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22902478)

  • 1. The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition.
    Bertrand T; Kothe M; Liu J; Dupuy A; Rak A; Berne PF; Davis S; Gladysheva T; Valtre C; Crenne JY; Mathieu M
    J Mol Biol; 2012 Oct; 423(3):439-53. PubMed ID: 22902478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of nonactive site, TrkA-selective kinase inhibitors.
    Su HP; Rickert K; Burlein C; Narayan K; Bukhtiyarova M; Hurzy DM; Stump CA; Zhang X; Reid J; Krasowska-Zoladek A; Tummala S; Shipman JM; Kornienko M; Lemaire PA; Krosky D; Heller A; Achab A; Chamberlin C; Saradjian P; Sauvagnat B; Yang X; Ziebell MR; Nickbarg E; Sanders JM; Bilodeau MT; Carroll SS; Lumb KJ; Soisson SM; Henze DA; Cooke AJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E297-E306. PubMed ID: 28039433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal Structures of Neurotrophin Receptors Kinase Domain.
    Bertrand T
    Vitam Horm; 2017; 104():1-18. PubMed ID: 28215291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trk kinase inhibitors as new treatments for cancer and pain.
    Wang T; Yu D; Lamb ML
    Expert Opin Ther Pat; 2009 Mar; 19(3):305-19. PubMed ID: 19441906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of trk receptors in the developing and adult human central and peripheral nervous system.
    Muragaki Y; Timothy N; Leight S; Hempstead BL; Chao MV; Trojanowski JQ; Lee VM
    J Comp Neurol; 1995 Jun; 356(3):387-97. PubMed ID: 7642800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p75 Co-receptors regulate ligand-dependent and ligand-independent Trk receptor activation, in part by altering Trk docking subdomains.
    Zaccaro MC; Ivanisevic L; Perez P; Meakin SO; Saragovi HU
    J Biol Chem; 2001 Aug; 276(33):31023-9. PubMed ID: 11425862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tyrosine kinase domain properties for the neurotrophin receptors TrkA and TrkB.
    Artim SC; Kiyatkin A; Lemmon MA
    Biochem J; 2020 Oct; 477(20):4053-4070. PubMed ID: 33043964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
    Eggert A; Ikegaki N; Liu XG; Brodeur GM
    Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dok5 is substrate of TrkB and TrkC receptors and involved in neurotrophin induced MAPK activation.
    Shi L; Yue J; You Y; Yin B; Gong Y; Xu C; Qiang B; Yuan J; Liu Y; Peng X
    Cell Signal; 2006 Nov; 18(11):1995-2003. PubMed ID: 16647839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application.
    Yan W; Lakkaniga NR; Carlomagno F; Santoro M; McDonald NQ; Lv F; Gunaganti N; Frett B; Li HY
    J Med Chem; 2019 Feb; 62(4):1731-1760. PubMed ID: 30188734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of trkA, trkB, and trkC in injured and regenerating retinal ganglion cells of adult rats.
    Cui Q; Tang LS; Hu B; So KF; Yip HK
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1954-64. PubMed ID: 12037005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular LINGO-1 negatively regulates Trk neurotrophin receptor signaling.
    Meabon JS; de Laat R; Ieguchi K; Serbzhinsky D; Hudson MP; Huber BR; Wiley JC; Bothwell M
    Mol Cell Neurosci; 2016 Jan; 70():1-10. PubMed ID: 26546150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Trk receptors following contusion of the rat spinal cord.
    Liebl DJ; Huang W; Young W; Parada LF
    Exp Neurol; 2001 Jan; 167(1):15-26. PubMed ID: 11161589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC.
    Ultsch MH; Wiesmann C; Simmons LC; Henrich J; Yang M; Reilly D; Bass SH; de Vos AM
    J Mol Biol; 1999 Jul; 290(1):149-59. PubMed ID: 10388563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chemical-genetic approach to studying neurotrophin signaling.
    Chen X; Ye H; Kuruvilla R; Ramanan N; Scangos KW; Zhang C; Johnson NM; England PM; Shokat KM; Ginty DD
    Neuron; 2005 Apr; 46(1):13-21. PubMed ID: 15820690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5.
    Banfield MJ; Naylor RL; Robertson AG; Allen SJ; Dawbarn D; Brady RL
    Structure; 2001 Dec; 9(12):1191-9. PubMed ID: 11738045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.
    Bailey JJ; Schirrmacher R; Farrell K; Bernard-Gauthier V
    Expert Opin Ther Pat; 2017 Jun; 27(6):733-751. PubMed ID: 28270010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR.
    Bibel M; Hoppe E; Barde YA
    EMBO J; 1999 Feb; 18(3):616-22. PubMed ID: 9927421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.
    Assimakopoulou M; Zolota V; Chondrogianni C; Gatzounis G; Varakis J
    Neuroendocrinology; 2008; 88(2):127-34. PubMed ID: 18319596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimerization of the Trk receptors in the plasma membrane: effects of their cognate ligands.
    Ahmed F; Hristova K
    Biochem J; 2018 Nov; 475(22):3669-3685. PubMed ID: 30366959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.